Jane Street Group, LLC Chembio Diagnostics, Inc. Call Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 16, 2021
SELL
$2.06 - $5.34 $7,004 - $18,156
-3,400 Reduced 11.76%
25,500 $64,000
Q4 2020

Feb 17, 2021
SELL
$4.11 - $7.51 $239,202 - $437,082
-58,200 Reduced 66.82%
28,900 $137,000
Q3 2020

Nov 17, 2020
BUY
$3.28 - $5.93 $285,688 - $516,503
87,100 New
87,100 $423,000

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email